WEBULL
News
NVAX
6.68
+2.30%
0.15
Noteworthy Tuesday Option Activity: NVAX, TKO, PYPL
NASDAQ · 2d ago
Pfizer leads COVID-19 vaccine peers lower after revamped guidance
Seeking Alpha · 2d ago
FDA Commissioner Makary says 'black box' warning not coming to COVID vaccines
Seeking Alpha · 3d ago
'FDA Chief Says No Plans To Put Boxed Warning On Covid Vaccines' - Bloomberg News
Benzinga · 3d ago
Weekly Report: what happened at NVAX last week (1208-1212)?
Weekly Report · 4d ago
Novavax (NVAX) Valuation Check as FDA Scrutiny Rises and Activist Pushes for Possible Sale
Simply Wall St · 5d ago
FDA Weighs Black Box Warning For COVID Vaccines, Experts Push Back
Benzinga · 6d ago
FDA plans to put “black box” warning on Covid vaccines: report
Seeking Alpha · 12/12 11:45
CDC study finds COVID shot significantly reduced ER visits for children
Seeking Alpha · 12/11 22:37
Why I Wouldn't Touch Novavax With a 10-Foot Pole
The Motley Fool · 12/11 18:01
Debate On Vaccine Safety Reaches Policy Stage - FDA Broadens Review Into Covid-19 Shot Risks In Adults
Benzinga · 12/10 12:59
FDA expands COVID-19 shot safety probe to include adults - report
Seeking Alpha · 12/09 22:34
U.S. Dept. Of Health And Human Services Says "Doing A Thorough Investigation, Across Multiple Age Groups, Of Deaths Potentially Related To Covid Vaccines"
Benzinga · 12/09 20:45
FDA PROBES IF COVID SHOTS MIGHT BE LINKED TO DEATHS OF ADULTS- BLOOMBERG NEWS
Reuters · 12/09 19:11
Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock
NASDAQ · 12/08 14:00
Weekly Report: what happened at NVAX last week (1201-1205)?
Weekly Report · 12/08 10:30
Novavax (NVAX): Revisiting Valuation After Prolonged Share Price Weakness and Mixed Fair Value Signals
Simply Wall St · 12/05 15:26
Is Novavax Now a Bargain After a 94.1% Five Year Share Price Slump?
Simply Wall St · 12/04 01:27
Former FDA commissioners castigate plan to change vaccine approval standards
Seeking Alpha · 12/03 22:40
Vaccine panel head who opposed COVID restrictions elevated to senior HHS role
Seeking Alpha · 12/02 15:11
More
Webull provides a variety of real-time NVAX stock news. You can receive the latest news about Novavax Inc through multiple platforms. This information may help you make smarter investment decisions.
About NVAX
Novavax, Inc. is a biotechnology company. It is focused on addressing global health challenges through its vaccines and its proven technology platform, including protein-based nanoparticles and its Matrix-M adjuvant. Matrix-M can be used to create vaccines for a variety of diseases to help tackle some of the pressing health challenges. Its proprietary Matrix-M adjuvant, when added to vaccines, has been shown to help induce a stronger and longer-lasting immune response. Its recombinant protein-based nanoparticle technology has been shown to be highly immunogenetic. Its technology platform is used in its authorized COVID-19 vaccine and the R21/Matrix-M adjuvant malaria vaccine. Its late-stage programs include a COVID-19-Influenzavaccine candidate, and an influenza vaccine candidate. R21/Matrix-M adjuvant malaria vaccine, a malaria vaccine developed by its partner. It provides Matrix-M adjuvant for use in various programs in preclinical and clinical stage, and preclinical investigations.